IGC News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

IG

Mkt Cap

$26.3M

Volume

398.17K

Next Earnings

November 13th

Chart Financials Earnings News About Insider Filings

Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsightOver 50 companies are advancing cannabinoid drug research, exploring potential treatments for mental health disorders, neurodegenerative diseases, and chronic inflammation, with promising clinical trials targeting conditions like Alzheimer's, pain management, and epilepsy.GlobeNewswire Inc. · Aug 12, 2025

Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsightThe cannabinoid agonist market is gaining momentum with expanding medical cannabis legalization and growing clinical validation for treating chronic pain, epilepsy, and inflammatory conditions. Over 20 pharmaceutical companies are actively developing cannabinoid agonist drugs with promising pipeline candidates.GlobeNewswire Inc. · Jul 10, 2025

Why VBI Vaccines Are Trading Lower By Over 23%; Here Are 20 Stocks Moving PremarketGainers Akumin Inc. (NASDAQ: AKU) shares surged 58.2% to $0.2865 in pre-market trading. Akumin recently named Krishna Kumar as President and Chief Operating Officer of the Company. Mullen Automotive, Inc. (NASDAQ: MULN) shares gained 52.8% to $0.2612 in pre-market trading. Mullen Automotive shares jumped 69% on Wednesday after the company announced the retention of a law group to investigate possible naked short selling. Micromobility.com Inc. (NASDAQ: MCOM) shares rose 19.8% to $0.1354 in pre-market trading. micromobility.com recently announced a strategic realignment to strengthen its financial position and drive profitability. Caravelle International Group (NASDAQ: CACO) rose 19.6% to $0.6399 in pre-market trading. AIM ImmunoTech Inc. (NYSE: AIM) gained 18.3% to $0.7690 in pre-market trading after declining 3% on Wednesday. Histogen Inc. (NASDAQ: HSTO) rose 18% to $0.8563 in pre-market trading. Histogen announced its decision to pause further development of its programs and commence a process to explore strategic alternatives. IGC Pharma, Inc. (NYSE: IGC) shares rose 14.7% to $0.39 in pre-market trading after gaining around 5% on Wednesday. IronNet, Inc. (NYSE: IRNT) shares climbed 13.9% to $0.2392 in pre-market trading after gaining ...Benzinga · Jul 6, 2023

IGC Announces Rebranding, Changes Name to IGC Pharma, Inc.POTOMAC, Md., March 20, 2023 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American: IGC) (“IGC” or the “Company”) today announces it will begin operating under the new name IGC Pharma, Inc., (dba IGC) effective March 30, 2023, as part of a rebranding strategy that better reflects IGC Pharma’s strategic focus and vision for the future.GlobeNewswire Inc. · Mar 20, 2023

IGC Reports Financial Results for Third Fiscal Quarter Ended Dec. 31, 2022POTOMAC, Md., Feb. 14, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- India Globalization Capital, Inc. (dba IGC, Inc.) (NYSE American: IGC) (“IGC” or the “Company”) today reported its third fiscal quarter 2023 financial results.GlobeNewswire Inc. · Feb 15, 2023

IGC to be Featured in Feb. 10 Radius Research Investor WebinarPOTOMAC, Md., Feb. 08, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- India Globalization Capital, Inc. (NYSE American: IGC) (“IGC” or the “Company”) today announces that Ram Mukunda, CEO, and Claudia Grimaldi, PFO, will be featured in an investor webinar hosted by Radius Research on Friday, Feb. 10, at 12:30 p.m. ET. They will discuss the Company’s Phase 2 trial for its drug candidate IGC-AD1 in treating agitation in dementia patients suffering from Alzheimer’s and will participate in a question and answer session.GlobeNewswire Inc. · Feb 8, 2023

IGC Announces Updated Life Sciences PresentationPOTOMAC, Md., Dec. 20, 2022 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American: IGC) (“IGC” or the “Company”), today announces that a life sciences presentation has been filed with the SEC on Form 8K and is available at https://www.sec.gov/.GlobeNewswire Inc. · Dec 20, 2022

IGC Applauds Signing of Bipartisan Medical Marijuana and Cannabidiol Research Expansion ActPOTOMAC, Md., Dec. 07, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- India Globalization Capital, Inc (NYSE American: IGC) (“IGC” or the “Company”), applauds the signing of the Medical Marijuana and Cannabidiol Research Expansion Act (“the Act”), which was signed into law by President Biden on Friday Dec. 2, 2022. The law provides legislation establishing a new registration process for conducting research on marijuana and for manufacturing marijuana products for research purposes and drug development.GlobeNewswire Inc. · Dec 7, 2022

IGC to Present at the RHK 2022 Disruptive Growth ConferencePOTOMAC, Md., Nov. 30, 2022 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc (NYSE American: IGC) (“IGC” or the “Company”) today announced that Ram Mukunda, Chief Executive Officer, will be presenting at the RHK Disruptive Growth Conference in New York City on Monday, December 5 at 11:20 am ET and will be available for one-on-one meetings on Monday, December 5 and Tuesday, December 6.GlobeNewswire Inc. · Nov 30, 2022

4 High Volume Penny Stocks To Watch While The Stock Market Is DownPenny stocks to buy? High volume has placed them on the watch list in the stock market today. The post 4 High Volume Penny Stocks To Watch While The Stock Market Is Down appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.PennyStocks · Sep 16, 2022

IG

IGCIGC Pharma, Inc.

IGC

Pay with—

Available Balance0.00

Your PositionYou don't own any IGC yet.

Related Tickers

Earnings